Formulation Development White Papers & Articles
-
Early Development Considerations For Late-Stage NCE Success – Part One
12/8/2023
Navigating NCE development can be daunting. Learn about the importance of assessing and mitigating risk at every stage of development and ensure that your NCE has the maximum potential for success.
-
What Information Does A CDMO Need To Deliver A Good Proposal?
12/6/2023
Learn about the importance of sharing as much information as possible with your CDMO and how asking the right set of questions will ensure that services are fairly priced and timelines are accurate.
-
Welcoming The “Era Of ADCs”
12/5/2023
Dr. Loretta Itri sat down to explore the promise of TRODELVY®️ and other antibody-drug conjugates as transformative treatments for a range of malignancies and intractable diseases.
-
Genome Editing Using mRNA-Lipid Nanoparticles For CAR T Cell Therapy
11/22/2023
Gene delivery platforms must support a diversity of genetic engineering strategies for genomic medicine development. Learn how lipid nanoparticles can accelerate development from discovery to scale-up.
-
Increasing Bioavailability With Amorphous Solid Dosage Formulations
11/10/2023
Discover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.
-
Nitrosamine Impurities Deadline: Are Your Products Compliant?
11/6/2023
The FDA nitrosamine contamination guidance set deadlines of Nov. 1, 2023, for risk assessment updates and Aug. 1, 2025, for full NDSRI limit compliance.
-
The Future Of ADC Manufacturing
11/2/2023
Enhance your ADC manufacturing processes by leveraging the performances and inherent benefits of single-use isolators.
-
Expanding Home-Based Care With A Next-Gen On-Body Delivery System
10/20/2023
As on-body delivery systems (OBDSs) enable the shift to patient-centric treatment, manufacturers must optimize the device and therapy formulation to minimize the risks and increase adherence.
-
Increasing Success Rates In Your Drug Discovery Research
10/17/2023
Learn about a reputable, highly diverse screening library and fragment collection that could pave your way through a successful discovery campaign.
-
Over The Hurdles: Taking Psychedelics From Schedule I To Pharmacy
10/12/2023
Learn how a partner with experience in handling scheduled substances and navigating FDA and DEA regulation can help you advance toward clinical research and drug development with ease.